Details for Patent: 3,927,046
✉ Email this page to a colleague
Summary for Patent: 3,927,046
Title: | Novel 11,11-alkylidene steroids |
Abstract: | The invention relates to novel 11,11-alkylidene steroids of the estrane and (19-nor-)pregnane series having a double bond starting from carbon atom 5, the alkylidene group in 11-position having the formula ##EQU1## wherein R.sub.1 and R.sub.2 are hydrogen or an alkyl group having 1-2 C-atoms, and to processes for their preparation. The novel compounds have very interesting biological activities, such as anabolic, androgenic, estrogenic, progestative, anti-androgenic, anti-oestrogenic, ovulation-inhibiting and gonad-inhibiting activities. |
Inventor(s): | van den Broek; Albertus Joannes (Oss, NL) |
Assignee: | Akzona Incorporated (Asheville, NC) |
Application Number: | 05/420,823 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 3,927,046
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 3,927,046
International Family Members for US Patent 3,927,046
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 367067 | ⤷ Try a Trial | |||
Austria | A1032373 | ⤷ Try a Trial | |||
Australia | 6326373 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |